Síndromes de choque tóxico

Detalhes bibliográficos
Autor(a) principal: Diogo Carvalho Pereira de Sá
Data de Publicação: 2018
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/114327
Resumo: Background: The staphylococcal TSS was first named in 1978 and it was associated two years later to the use of vaginal tampons. In 1987, the streptococcal TSS was described in patients who had invasive Streptococcus pyogenes infections. The ultimate goal of this review was, through the gathering of information, to aid clinicians in their practice. Methods: A Pubmed search was conducted using the hereunder keywords. Other articles were added through the review of the selected articles' references. Relevant websites were also included. Results: Since the 80s the incidence of staphylococcal TSS has declined with the mortality rate being higher in menstrual TSS. Although being less frequent, the streptococcal TSS has a higher mortality rate. This syndromes are caused by the production of superantigens that over activate in a non-conventional way the T-cells, with a massive release of inflammatory cytokines. The progression to multiple organ dysfunction can happen fast with other symptoms such as hypotension, rash, fever and cutaneous desquamation. The treatment comprises the identification of possible sources of infection and their removal, intensive care support, broad-spectrum antibiotics including clindamycin and the patient can also benefit from the administration of intravenous immunoglobulin. Discussion: It is essential to continue the research in this area with focus on the treatment. Future studies can explore the therapeutic potential of monoclonal antibodies and Vβ proteins. Conclusion: Proper timing and adequacy of diagnosis and treatment of TSS are of paramount importance to reduce the high levels of morbidity and mortality of this syndrome. Keywords: Toxic shock syndrome; Septic shock; Superantigens; Staphylococcus aureus; Streptococcus pyogenes.
id RCAP_d9001f42b01dbdbd4fb60fe235238fea
oai_identifier_str oai:repositorio-aberto.up.pt:10216/114327
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Síndromes de choque tóxicoMedicina clínicaClinical medicineBackground: The staphylococcal TSS was first named in 1978 and it was associated two years later to the use of vaginal tampons. In 1987, the streptococcal TSS was described in patients who had invasive Streptococcus pyogenes infections. The ultimate goal of this review was, through the gathering of information, to aid clinicians in their practice. Methods: A Pubmed search was conducted using the hereunder keywords. Other articles were added through the review of the selected articles' references. Relevant websites were also included. Results: Since the 80s the incidence of staphylococcal TSS has declined with the mortality rate being higher in menstrual TSS. Although being less frequent, the streptococcal TSS has a higher mortality rate. This syndromes are caused by the production of superantigens that over activate in a non-conventional way the T-cells, with a massive release of inflammatory cytokines. The progression to multiple organ dysfunction can happen fast with other symptoms such as hypotension, rash, fever and cutaneous desquamation. The treatment comprises the identification of possible sources of infection and their removal, intensive care support, broad-spectrum antibiotics including clindamycin and the patient can also benefit from the administration of intravenous immunoglobulin. Discussion: It is essential to continue the research in this area with focus on the treatment. Future studies can explore the therapeutic potential of monoclonal antibodies and Vβ proteins. Conclusion: Proper timing and adequacy of diagnosis and treatment of TSS are of paramount importance to reduce the high levels of morbidity and mortality of this syndrome. Keywords: Toxic shock syndrome; Septic shock; Superantigens; Staphylococcus aureus; Streptococcus pyogenes.2018-07-312018-07-31T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttps://hdl.handle.net/10216/114327TID:202407349porDiogo Carvalho Pereira de Sáinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T16:09:34Zoai:repositorio-aberto.up.pt:10216/114327Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T00:38:21.347687Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Síndromes de choque tóxico
title Síndromes de choque tóxico
spellingShingle Síndromes de choque tóxico
Diogo Carvalho Pereira de Sá
Medicina clínica
Clinical medicine
title_short Síndromes de choque tóxico
title_full Síndromes de choque tóxico
title_fullStr Síndromes de choque tóxico
title_full_unstemmed Síndromes de choque tóxico
title_sort Síndromes de choque tóxico
author Diogo Carvalho Pereira de Sá
author_facet Diogo Carvalho Pereira de Sá
author_role author
dc.contributor.author.fl_str_mv Diogo Carvalho Pereira de Sá
dc.subject.por.fl_str_mv Medicina clínica
Clinical medicine
topic Medicina clínica
Clinical medicine
description Background: The staphylococcal TSS was first named in 1978 and it was associated two years later to the use of vaginal tampons. In 1987, the streptococcal TSS was described in patients who had invasive Streptococcus pyogenes infections. The ultimate goal of this review was, through the gathering of information, to aid clinicians in their practice. Methods: A Pubmed search was conducted using the hereunder keywords. Other articles were added through the review of the selected articles' references. Relevant websites were also included. Results: Since the 80s the incidence of staphylococcal TSS has declined with the mortality rate being higher in menstrual TSS. Although being less frequent, the streptococcal TSS has a higher mortality rate. This syndromes are caused by the production of superantigens that over activate in a non-conventional way the T-cells, with a massive release of inflammatory cytokines. The progression to multiple organ dysfunction can happen fast with other symptoms such as hypotension, rash, fever and cutaneous desquamation. The treatment comprises the identification of possible sources of infection and their removal, intensive care support, broad-spectrum antibiotics including clindamycin and the patient can also benefit from the administration of intravenous immunoglobulin. Discussion: It is essential to continue the research in this area with focus on the treatment. Future studies can explore the therapeutic potential of monoclonal antibodies and Vβ proteins. Conclusion: Proper timing and adequacy of diagnosis and treatment of TSS are of paramount importance to reduce the high levels of morbidity and mortality of this syndrome. Keywords: Toxic shock syndrome; Septic shock; Superantigens; Staphylococcus aureus; Streptococcus pyogenes.
publishDate 2018
dc.date.none.fl_str_mv 2018-07-31
2018-07-31T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/114327
TID:202407349
url https://hdl.handle.net/10216/114327
identifier_str_mv TID:202407349
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799136290855190528